Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
Triple-leveraged LABU multiplies daily biotech index returns threefold, offering amplified gains and losses tied to biotech FDA catalysts and sector momentum.
FDA approves updated covid vaccines, but with severe new limits
FDA approved COVID-19 vaccines for seniors 65+ and high-risk individuals while revoking Pfizer's EUA for children under 5; CDC director Susan Monarez's status is contested.